The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney.
It is generally accepted that iron homeostasis is mainly controlled in the gastrointestinal tract by absorption of dietary iron. However, recent studies have shown that the kidneys are also involved in iron metabolism. Since the iron-regulatory and antimicrobial peptide hormone hepcidin was originally isolated from human urine we have investigated the expression as well as the zonal and cellular localization of hepcidin in the mammalian kidney and developed an ELISA assay to analyze hepcidin concentrations in serum and urine. The expression of hepcidin was shown by RT-PCR and immunoblot experiments; its cellular localization was studied by immunocytochemistry in human, mouse and rat kidney, which revealed similar patterns of immunoreactivity. Hepcidin expression was absent from the proximal tubule and descending and ascending thin limbs. There was strong expression in the thick ascending limb of the cortex and in connecting tubules. Moderate expression was noted in the thick ascending limb and collecting ducts of the medulla and in collecting ducts of the papilla. Importantly, the cells of the macula densa were unstained. At the cellular level, hepcidin was localized to the apical cell pole of the renal epithelial cells. Based on its presence in urine, hepcidin may be released apically into the urine. Enhanced levels of hepcidin were determined in patients with chronic renal insuffciency (156.8 ng/ml, controls 104.2 ng/ml) indicating that the kidneys may metabolize and/or eliminate the circulating peptide. From the expression of hepcidin in the mammalian kidney, we have concluded that the iron-regulatory hormone is an intrinsic renal peptide which is not only eliminated by the kidney but is also synthesized in the kidney tubular system. Localization of hepcidin in the kidney implicates an iron-regulatory role of this peptide hormone in the renal tubular system, possibly in connection with the iron transporter divalent metal transporter-1.
Kulaksiz
H
H
Department of Internal Medicine, Division of Gastroenterology, Im Neuenheimer Feld 410, University Hospital Heidelberg, D-69121 Heidelberg, Germany. Hasan.Kulaksiz@med.uni-heidelberg.de
Theilig
F
F
Bachmann
S
S
Gehrke
S G
SG
Rost
D
D
Janetzko
A
A
Cetin
Y
Y
Stremmel
W
W
D000328:Adult; D000818:Animals; D023181:Antimicrobial Cationic Peptides / Q000032:analysis* / Q000096:biosynthesis; D016022:Case-Control Studies; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D004847:Epithelial Cells / Q000737:chemistry; D005260:Female; D064451:Hepcidins; D006706:Homeostasis; D006801:Humans; D015151:Immunoblotting; D007150:Immunohistochemistry / Q000379:methods; D007501:Iron / Q000378:metabolism; D007668:Kidney / Q000737:chemistry* / Q000378:metabolism; D007676:Kidney Failure, Chronic / Q000378:metabolism; D007684:Kidney Tubules / Q000737:chemistry / Q000378:metabolism; D008099:Liver / Q000737:chemistry / Q000378:metabolism; D008297:Male; D051379:Mice; D051381:Rats; D020133:Reverse Transcriptase Polymerase Chain Reaction
D023181:Antimicrobial Cationic Peptides; C578702:HAMP protein, human; C579599:Hamp protein, mouse; C578703:Hamp protein, rat; D064451:Hepcidins; D007501:Iron